Journal
NATURE BIOTECHNOLOGY
Volume 38, Issue 11, Pages 1242-1252Publisher
NATURE RESEARCH
DOI: 10.1038/s41587-020-0732-8
Keywords
-
Categories
Ask authors/readers for more resources
With the first readouts of trials of antibodies against COVID-19 appearing and others coming thick and fast, Nature Biotechnology asked a group of experts to comment on the challenges and timelines for these products.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
